Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Leconte

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Case Reports in Oncology|April 18, 2022
BRCA1 Mutation: An Insidious Enemy with Multiple Facets…Pierrick Godin, Francois P Duhoux, Filomena Mazzeo, et al.
Pharmaceutics|September 28, 2021
Safety Testing of an Antisense Oligonucleotide Intended for Pediatric Indications in the Juvenile Göttingen Minipig, including an Evaluation of the Ontogeny of Key NucleasesAllan Valenzuela, Claire Tardiveau, Miriam Ayuso, et al.
Reproductive Toxicology (Elmsford, N.Y.)|August 30, 2025
New approach methodologies for assessing developmental toxicity of pharmaceuticals: Case Examples and Future DirectionsNicola Powles-Glover, Allen R Kaczor, Steven Van Cruchten, et al.
Journal of the American College of Cardiology|April 23, 2003
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertensionNazzareno Galiè, Alan L Hinderliter, Adam Torbicki, et al.
Nucleic Acid Therapeutics|May 30, 2025
Developmental and Reproductive Toxicity Testing Strategies for Oligonucleotides: A Workshop ProceedingsBethany R Hannas, Sara M Bender, Eileen Blasi, et al.
Toxicology Letters|June 26, 2016
The European Registered Toxicologist (ERT): Current status and prospects for advancementMartin F Wilks, Bas J Blaauboer, Rolf Schulte-Hermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2025
Amivantamab Plus Lazertinib in Atypical <i>EGFR</i>-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2Pascale Tomasini, Yongsheng Wang, Yongsheng Li, et al.
Communications Physics|May 1, 2023
The Extremely Brilliant Source storage ring of the European Synchrotron Radiation FacilityPantaleo Raimondi, Chamseddine Benabderrahmane, Paul Berkvens, et al.
The New England Journal of Medicine|June 26, 2024
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLCByoung C Cho, Shun Lu, Enriqueta Felip, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Case Reports in Oncology|April 18, 2022
BRCA1 Mutation: An Insidious Enemy with Multiple Facets…Pierrick Godin, Francois P Duhoux, Filomena Mazzeo, et al.
Pharmaceutics|September 28, 2021
Safety Testing of an Antisense Oligonucleotide Intended for Pediatric Indications in the Juvenile Göttingen Minipig, including an Evaluation of the Ontogeny of Key NucleasesAllan Valenzuela, Claire Tardiveau, Miriam Ayuso, et al.
Reproductive Toxicology (Elmsford, N.Y.)|August 30, 2025
New approach methodologies for assessing developmental toxicity of pharmaceuticals: Case Examples and Future DirectionsNicola Powles-Glover, Allen R Kaczor, Steven Van Cruchten, et al.
Journal of the American College of Cardiology|April 23, 2003
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertensionNazzareno Galiè, Alan L Hinderliter, Adam Torbicki, et al.
Nucleic Acid Therapeutics|May 30, 2025
Developmental and Reproductive Toxicity Testing Strategies for Oligonucleotides: A Workshop ProceedingsBethany R Hannas, Sara M Bender, Eileen Blasi, et al.
Toxicology Letters|June 26, 2016
The European Registered Toxicologist (ERT): Current status and prospects for advancementMartin F Wilks, Bas J Blaauboer, Rolf Schulte-Hermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2025
Amivantamab Plus Lazertinib in Atypical <i>EGFR</i>-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2Pascale Tomasini, Yongsheng Wang, Yongsheng Li, et al.
Communications Physics|May 1, 2023
The Extremely Brilliant Source storage ring of the European Synchrotron Radiation FacilityPantaleo Raimondi, Chamseddine Benabderrahmane, Paul Berkvens, et al.
The New England Journal of Medicine|June 26, 2024
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLCByoung C Cho, Shun Lu, Enriqueta Felip, et al.
Pageof 3